Home
StockRanks™
Platform
Reviews
Pricing

Get started Log in

Sectors Healthcare Biotechnology & Medical ResearchInhibikase Therapeutics

IKT — Inhibikase Therapeutics Share News

$1.700.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Market Cap
$205.53m
Enterprise Value
$128.21m
Revenue

Quality
41
Value
21
Momentum
41
StockRank™
24

StockReport™
Accounts
News
IKT Dividends

StockReport™

Balance sheet

Income statement

Cashflow

News

IKT Dividends

Company

About us
Careers
Product Guide

Our Coverage

Countries
Sectors
Ratios

Top Stocks

UK Stocks
Australian Stocks
US Stocks

Legals

Privacy Policy
Terms & Conditions
Disclaimer & FSG
Cookies

Select a country/region:

© Stockopedia 2026, Refinitiv, Share Data Services.

*Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.